Cognitive & NeurologicalModerate EvidenceDihexa

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) Produces Robust Cognitive Enhancement in Aged Rats

McCoy AT, Benoist CC, Wright JW, Kawas LH, Bhatt DL, Bhatt S, Harding JW

Journal of Pharmacology and Experimental Therapeutics · Vol. 347(2) · pp. 374–382 · 2013

Demonstrates that Dihexa, a potent HGF/MET activator derived from angiotensin IV, produces dramatic cognitive enhancement in aged rats — reportedly 7 orders of magnitude more potent than BDNF at promoting synaptogenesis. Establishes Dihexa as a candidate for Alzheimer's and age-related cognitive decline.

Citation

Journal
Journal of Pharmacology and Experimental Therapeutics
Year
2013
DOI
10.1124/jpet.113.206938
View on DOI.org

Key Findings

1

Dihexa is approximately 10 million times more potent than BDNF at promoting synaptogenesis

2

Significant improvement in spatial memory and learning in aged rat models

3

Activates HGF/MET signaling pathway to promote dendritic spine formation

4

Reverses cognitive deficits induced by scopolamine (cholinergic blockade)

5

Orally bioavailable and CNS-penetrant — crosses blood-brain barrier effectively

Methodology

Aged rat cognitive testing using Morris water maze and novel object recognition. Synaptogenesis quantification via dendritic spine counting and HGF/MET pathway analysis.

Limitations

Animal data only; no human clinical trials published. Potency claims require independent replication. Long-term safety unknown.

Tags

DihexaCognitive EnhancementHGFSynaptogenesisAlzheimer'sMemoryNootropic

Educational use only. Research summaries are provided for informational purposes. Always consult the original publication and a qualified healthcare provider before making clinical decisions.

Build a protocol around this research

Our AI Advisor incorporates the latest research to build a personalized peptide protocol for your goals.

Start Assessment